Your browser doesn't support javascript.
loading
The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors.
Quigley, David A; Fiorito, Elisa; Nord, Silje; Van Loo, Peter; Alnæs, Grethe Grenaker; Fleischer, Thomas; Tost, Jorg; Moen Vollan, Hans Kristian; Tramm, Trine; Overgaard, Jens; Bukholm, Ida R; Hurtado, Antoni; Balmain, Allan; Børresen-Dale, Anne-Lise; Kristensen, Vessela.
Afiliação
  • Quigley DA; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Helen Diller Family Comprehensive Cancer Center, Univ
  • Fiorito E; Breast Cancer Research Group, Nordic EMBL Partnership, Centre for Molecular Medicine Norway, (NCMM), University of Oslo, Norway. Electronic address: elisa.fiorito@ncmm.uio.no.
  • Nord S; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: silje.nord@rr-research.no.
  • Van Loo P; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton UK; Department of Human Genetics, VIB and KU Leuven, Leuven, Belgium. Electronic address: pvl@sanger.ac.uk.
  • Alnæs GG; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: Grethe.I.Grenaker.Alnas@rr-resear
  • Fleischer T; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: thofle@rr-research.no.
  • Tost J; Laboratory for Functional Genomics, Fondation Jean Dausset, Centre Etude Polymorphism Humain, (CEPH), Paris, France; Laboratory of Epigenetics, Centre National de Génotypage, Commissariat à l'énergie Atomique et, aux énergies Alternatives (CEA)-Institut de Génomique, Evry, France. Electronic address
  • Moen Vollan HK; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: Hans.Kristian.Moen.Vollan@rr-rese
  • Tramm T; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: TRAMM@ONCOLOGY.DK.
  • Overgaard J; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: jens@oncology.dk.
  • Bukholm IR; Department of Breast-Endocrine Surgery, Akershus University Hospital, Oslo, Norway; Department of Oncology, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Oslo, Norway. Electronic address: i.r.k.bukholm@medisin.uio.no.
  • Hurtado A; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Breast Cancer Research Group, Nordic EMBL Partnership
  • Balmain A; Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, USA. Electronic address: abalmain@cc.ucsf.edu.
  • Børresen-Dale AL; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: a.l.borresen-dale@medisin.uio.no.
  • Kristensen V; Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), Me
Mol Oncol ; 8(2): 273-84, 2014 Mar.
Article em En | MEDLINE | ID: mdl-24388359
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Estrogênio / Regulação Neoplásica da Expressão Gênica / Predisposição Genética para Doença / Locos de Características Quantitativas / Alelos / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Oncol Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Estrogênio / Regulação Neoplásica da Expressão Gênica / Predisposição Genética para Doença / Locos de Características Quantitativas / Alelos / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Oncol Ano de publicação: 2014 Tipo de documento: Article